Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C13H14N2O4S2 |
| Molecular Weight | 326.391 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(=O)[C@]23CC4=CC=C[C@H](O)[C@H]4N2C(=O)[C@@]1(CO)SS3
InChI
InChIKey=FIVPIPIDMRVLAY-RBJBARPLSA-N
InChI=1S/C13H14N2O4S2/c1-14-10(18)12-5-7-3-2-4-8(17)9(7)15(12)11(19)13(14,6-16)21-20-12/h2-4,8-9,16-17H,5-6H2,1H3/t8-,9-,12+,13+/m0/s1
| Molecular Formula | C13H14N2O4S2 |
| Molecular Weight | 326.391 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Gliotoxin is a potent crystalline antibiotic substance produced during the growth of the imperfect fungus Gliocladium jimbriatum. It is a natural mycotoxin with immunosuppressive and antimicrobial activity. Gliotoxin acts as NOTCH2 transactivation inhibitor in human neoplasias. It induced growth inhibition and apoptosis in multiple colorectal cancer cell lines with mutations of the Wnt signaling pathway. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with pronounced antitumor activity and favorable toxicity profile against breast cancer in vitro and in vivo.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: map04210 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11522753 |
|||
Target ID: CHEMBL2094108 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15034210 |
80.0 µM [IC50] | ||
Target ID: CHEMBL2095164 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15034210 |
17.0 µM [IC50] | ||
Target ID: map04310 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26445050 |
|||
Target ID: NOTCH2 transactivation Sources: https://www.ncbi.nlm.nih.gov/pubmed/28736522 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| PKCdelta-mediated regulation of FLIP expression in human colon cancer cells. | 2006-01-15 |
|
| The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. | 2005-10 |
|
| LaeA, a regulator of morphogenetic fungal virulence factors. | 2005-09 |
|
| Thiopental-induced apoptosis in lymphocytes is independent of CD95 activation. | 2005-09 |
|
| Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. | 2005-08 |
|
| Bioinformatic and expression analysis of the putative gliotoxin biosynthetic gene cluster of Aspergillus fumigatus. | 2005-07-15 |
|
| Enhanced human beta-defensin-2 (hBD-2) expression by corticosteroids is independent of NF-kappaB in colonic epithelial cells (CaCo2). | 2005-07 |
|
| Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, induces apoptosis in multiple myeloma cells in an IkappaBalpha-independent manner. | 2005-07 |
|
| Gliotoxin-induced cytotoxicity in three salmonid cell lines: cell death by apoptosis and necrosis. | 2005-06 |
|
| The mycotoxins citrinin and gliotoxin differentially affect production of the pro-inflammatory cytokines tumour necrosis factor-alpha and interleukin-6, and the anti-inflammatory cytokine interleukin-10. | 2005-06 |
|
| Aspergillus mycotoxins and their effect on the host. | 2005-05 |
|
| Anandamide induces necrosis in primary hepatic stellate cells. | 2005-05 |
|
| The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis. | 2005-04 |
|
| Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. | 2005-03-15 |
|
| Genes and molecules involved in Aspergillus fumigatus virulence. | 2005-03 |
|
| The ABC transporter gene in the sirodesmin biosynthetic gene cluster of Leptosphaeria maculans is not essential for sirodesmin production but facilitates self-protection. | 2005-03 |
|
| NF-kappaB inhibition accelerates apoptosis of bovine neutrophils. | 2005-02-22 |
|
| Fungal populations and mycotoxins in silage in Assiut and Sohag governorates in Egypt, with a special reference to characteristic Aspergilli toxins. | 2005-02 |
|
| TNF-alpha expression is transcriptionally regulated by RANK ligand. | 2005-02 |
|
| Production of gliotoxin on natural substrates by Trichoderma virens. | 2005 |
|
| Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunit. | 2004-12-10 |
|
| Gliotoxins disrupt alanine metabolism and glutathione production in C6 glioma cells: a 13C NMR spectroscopic study. | 2004-12 |
|
| Directed biosynthesis of fluorinated pseurotin A, synerazol and gliotoxin. | 2004-11 |
|
| Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease. | 2004-11 |
|
| [Chemistry and biological effects of gliotoxin]. | 2004-11 |
|
| Reversible disruption of tight junction complexes in the rat blood-brain barrier, following transitory focal astrocyte loss. | 2004-10 |
|
| Gliotoxin induces Mg2+ efflux from intact brain mitochondria. | 2004-10 |
|
| Effect and stability of gliotoxin, an Aspergillus fumigatus toxin, on in vitro rumen fermentation. | 2004-09 |
|
| The sirodesmin biosynthetic gene cluster of the plant pathogenic fungus Leptosphaeria maculans. | 2004-09 |
|
| Comparing a ciliate and a fish cell line for their sensitivity to several classes of toxicants by the novel application of multiwell filter plates to Tetrahymena. | 2004-08-11 |
|
| Amphotericin B enhances the synthesis and release of the immunosuppressive agent gliotoxin from the pulmonary pathogen Aspergillus fumigatus. | 2004-08 |
|
| Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide. | 2004-07-01 |
|
| Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella. | 2004-07 |
|
| Cytotoxic substances from Aspergillus fumigatus in oxygenated or poorly oxygenated environment. | 2004-07 |
|
| Allergen activates peripheral blood eosinophil nuclear factor-kappaB to generate granulocyte macrophage-colony stimulating factor, tumour necrosis factor-alpha and interleukin-8. | 2004-07 |
|
| Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. | 2004-07 |
|
| Anti-apoptotic effect of nerve growth factor is lost in congenital insensitivity to pain with anhidrosis (CIPA) B lymphocytes. | 2004-05 |
|
| Effect of aeration on gliotoxin production by Aspergillus fumigatus in its culture filtrate. | 2004-04 |
|
| Cytotoxicity of fungal metabolites to lepidopteran (Spodoptera frugiperda) cell line (SF-9). | 2004-02 |
|
| Detection of Aspergillus fumigatus mycotoxins: immunogen synthesis and immunoassay development. | 2004-02 |
|
| Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012. | 2004-01-01 |
|
| Effect of aeration on gliotoxin production by Aspergillus fumigatus in its culture filtrate. | 2004-01 |
|
| Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo. | 2004 |
|
| Influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in Jurkat T cells and human peripheral blood cells: anti-inflammatory and cytotoxic effects. | 2003-12-01 |
|
| Evidence for radiosensitizing by gliotoxin in HL-60 cells: implications for a role of NF-kappaB independent mechanisms. | 2003-11-27 |
|
| Pyrazino[1,2-a]indole-1,4-diones, simple analogues of gliotoxin, as selective inhibitors of geranylgeranyltransferase I. | 2003-11-03 |
|
| Concentration-dependent atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds. | 2003-11 |
|
| Increasing local levels of neuregulin (glial growth factor-2) by direct infusion into areas of demyelination does not alter remyelination in the rat CNS. | 2003-10 |
|
| Accumulation of gliotoxin, a cytotoxic mycotoxin from Aspergillus fumigatus, in blue mussel (Mytilus edulis). | 2003-09 |
|
| Concentration-dependent preferences of absorptive and excretive transport cause atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds. | 2002 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11522753
Rat: 3 mg/kg body wt
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11522753
Culture-activated (14-day) rat Hepatic stellate cells (HSCs) and Culture-activated (24-day) human (H2) HSCs cells were treated for 4 hours with 1.5 umol/L gliotoxin. Rat and human HSCs resulted in striking morphologic alterations within 1 hour as judged by light microscopy. HSCs changed from a flattened fibroblastic phenotype with distinct cell-cell interfaces to a substratum-detached, rounded, and blebbed morphology.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:14:13 GMT 2025
by
admin
on
Mon Mar 31 22:14:13 GMT 2025
|
| Record UNII |
5L648PH06K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C574
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
||
|
NCI_THESAURUS |
C747
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Gliotoxin
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
PRIMARY | |||
|
DTXSID60877179
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
PRIMARY | |||
|
102866
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
PRIMARY | |||
|
6223
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
PRIMARY | |||
|
C63680
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
PRIMARY | NCIT | ||
|
5L648PH06K
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
PRIMARY | |||
|
m5746
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
PRIMARY | Merck Index | ||
|
5L648PH06K
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
PRIMARY | |||
|
67-99-2
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
PRIMARY | |||
|
1661743
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
PRIMARY | RxNorm | ||
|
5385
Created by
admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
|
PRIMARY |